Stopping GLP-1
Discontinuation and Regain Prevention Plan
If you are stopping GLP-1, use a structured discontinuation plan with taper strategy, monitoring windows, and regain prevention triggers.
A practical stop plan with objective checkpoints
Stopping GLP-1 without a plan usually turns into rapid appetite rebound and weight regain. A structured discontinuation protocol can reduce slope, improve control, and protect long-term outcomes.
This aspect of the Glp1 Discontinuation Regain Prevention protocol is particularly important for users who are tracking their response data systematically. Documenting your experience at each stage provides the longitudinal evidence needed to evaluate protocol effectiveness and make informed adjustments. Shotlee captures these data points automatically, building a comprehensive record that supports evidence-based decision making with your healthcare provider.
Discontinuation strategy fundamentals
Execution quality, not novelty, usually determines outcome quality. Keep the protocol simple, measurable, and reviewable every week. When variables change, tag the change and monitor the next 7 to 14 days as a dedicated observation window before making additional adjustments.
Discontinuation checklist
This aspect of the Glp1 Discontinuation Regain Prevention protocol is particularly important for users who are tracking their response data systematically. Documenting your experience at each stage provides the longitudinal evidence needed to evaluate protocol effectiveness and make informed adjustments. Shotlee captures these data points automatically, building a comprehensive record that supports evidence-based decision making with your healthcare provider.
Decision matrix
Control Why it matters What to track Escalation trigger
This aspect of the Glp1 Discontinuation Regain Prevention protocol is particularly important for users who are tracking their response data systematically. Documenting your experience at each stage provides the longitudinal evidence needed to evaluate protocol effectiveness and make informed adjustments. Shotlee captures these data points automatically, building a comprehensive record that supports evidence-based decision making with your healthcare provider.
Execution playbook
How Shotlee helps
shotleeFeatures
Guide FAQs
If you are stopping GLP-1, use a structured discontinuation plan with taper strategy, monitoring windows, and regain prevention triggers.
Yes. Shotlee supports tracking doses, side effects, and health metrics. It is free.
References
- [1]Clinical TrialWilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension). Diabetes Obes Metab. 2022;24:1553-1564.
- [2]Clinical TrialGarvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28:2083-2091.
- [3]Clinical TrialAronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4). JAMA. 2024;331(1):38-48.
Track Your GLP-1 Discontinuation Regain Prevention Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
๐ Use Shotlee for Free